Drug therapy for myocarditis induced by immune checkpoint inhibitors
Immune checkpoint inhibitors (ICIs), including cytotoxic T-lymphocyte antigen 4 (CTLA-4), programmed cell death 1 (PD-1), and its ligand 1 (PD-L1), have improved the survival in multiple types of cancers; however, ICIs may cause cardiovascular toxicity. Although rare, ICI-mediated cardiotoxicity is...
Saved in:
Main Authors: | Yihao Wu (Author), Yizhou Xu (Author), Linhao Xu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Myocarditis Induced by Immune Checkpoint Inhibitors: Mechanisms and Therapeutic Prospects
by: Zou W, et al.
Published: (2021) -
Usefulness of Longitudinal Strain to Assess Cancer Therapy-Related Cardiac Dysfunction and Immune Checkpoint Inhibitor-Induced Myocarditis
by: Yudai Tamura, et al.
Published: (2023) -
A model-informed approach to assess the risk of immune checkpoint inhibitor-induced autoimmune myocarditis
by: Solveig A. van der Vegt, et al.
Published: (2022) -
Intrinsic Differences in Immune Checkpoint Inhibitor-Induced Myocarditis: A Retrospective Analysis of Real World Data
by: Yanna Lei, et al.
Published: (2022) -
Neural Net Modeling of Checkpoint Inhibitor Related Myocarditis and Steroid Response
by: Stefanovic F, et al.
Published: (2022)